Crystal structure of an EfPDF complex with Met-Ala-Ser based on crystallographic packing

Biochemical and Biophysical Research Communications

Volumn 381, Issue 4, 2009, Pages 630-633

  Nam, Ki Hyun ^a   Kim, Kook Han ^a,b   Kim, Eunice Eun Kyeong ^b   Hwang, Kwang Yeon ^a  

^a Korea University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Antibacterial drug design; EfPDF MAS; PDF; Peptide deformylase

Indexed keywords

BACTERIAL PROTEIN; FORMYLPEPTIDE; PEPTIDE DEFORMYLASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ENTEROCOCCUS FAECIUM; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

AMIDOHYDROLASES; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; ENTEROCOCCUS FAECIUM; OLIGOPEPTIDES; PROTEIN CONFORMATION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; PROKARYOTA;

EID: 62649139034     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.113     Document Type: Article

References (29)

1. Meinnel T., and Blanquet S. Characterization of the Thermus thermophilus locus encoding peptide deformylase and methionyl-tRNA(fMet) formyltransferase. J. Bacteriol. 176 (1994) 7387-7390
2. Margolis P.S., Hackbarth C.J., Young D.C., Wang W., Chen D., Yuan Z., White R., and Trias J. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob. Agents Chemother. 44 (2000) 1825-1831
3. Clements J.M., Beckett R.P., Brown A., Catlin G., Lobell M., Palan S., Thomas W., Whittaker M., Wood S., Salama S., Baker P.J., Rodgers H.F., Barynin V., Rice D.W., and Hunter M.G. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob. Agents Chemother. 45 (2001) 563-570
4. Solbiati J., Chapman-Smith A., Miller J.L., Miller C.G., and Cronan Jr. J.E. Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal. J. Mol. Biol. 290 (1999) 607-614
5. Chen D., Hackbarth C., Ni Z.J., Wu C., Wang W., Jain R., He Y., Bracken K., Weidmann B., Patel D.V., Trias J., White R.J., and Yuan Z. Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach. Antimicrob. Agents Chemother. 48 (2004) 250-261
6. Kozak M. Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol. Rev. 47 (1983) 1-45
7. Hao B., Gong W., Rajagopalan P.T., Zhou Y., Pei D., and Chan M.K. Structural basis for the design of antibiotics targeting peptide deformylase. Biochemistry 38 (1999) 4712-4719
8. Becker A., Schlichting I., Kabsch W., Groche D., Schultz S., and Wagner A.F. Iron center, substrate recognition and mechanism of peptide deformylase. Nat. Struct. Biol. 5 (1998) 1053-1058
9. Chen D.Z., Patel D.V., Hackbarth C.J., Wang W., Dreyer G., Young D.C., Margolis P.S., Wu C., Ni Z.J., Trias J., White R.J., and Yuan Z. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry 39 (2000) 1256-1262
10. Jain R., Chen D., White R.J., Patel D.V., and Yuan Z. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents. Curr. Med. Chem. 12 (2005) 1607-1621
11. Yuan Z., and White R.J. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics. Biochem. Pharmacol. 71 (2006) 1042-1047
12. Wise R., Andrews J.M., and Ashby J. In vitro activities of peptide deformylase inhibitors against gram-positive pathogens. Antimicrob. Agents Chemother. 46 (2002) 1117-1118
13. Baldwin E.T., Harris M.S., Yem A.W., Wolfe C.L., Vosters A.F., Curry K.A., Murray R.W., Bock J.H., Marshall V.P., Cialdella J.I., Merchant M.H., Choi G., and Deibel Jr. M.R. Crystal structure of type II peptide deformylase from Staphylococcus aureus. J. Biol. Chem. 277 (2002) 31163-31171
14. Lee M.D., She Y., Soskis M.J., Borella C.P., Gardner J.R., Hayes P.A., Dy B.M., Heaney M.L., Philips M.R., Bornmann W.G., Sirotnak F.M., and Scheinberg D.A. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics. J. Clin. Invest. 114 (2004) 1107-1116
15. Xu Y., Lai L.T., Gabrilove J.L., and Scheinberg D.A. Antitumor activity of actinonin in vitro and in vivo. Clin. Cancer Res. 4 (1998) 171-176
16. Giglione C., Serero A., Pierre M., Boisson B., and Meinnel T. Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms. EMBO J. 19 (2000) 5916-5929
17. Nam K.H., Ham J.I., Priyadarshi A., Kim E.E., Chung N., and Hwang K.Y. Insight into the antibacterial drug design and architectural mechanism of peptide recognition from the E. faecium peptide deformylase structure. Proteins 74 (2009) 261-265
18. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
19. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., and Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
20. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 2126-2132
21. Laskowski P.A., McArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26 (1993) 283-291
22. Laskowski R.A. PDBsum: summaries and analyses of PDB structures. Nucleic Acids Res. 29 (2001) 221-222
23. Matthews B.W. Solvent content of protein crystals. J. Mol. Biol. 33 (1968) 491-497
24. W.L. DeLano, The PyMOL molecular graphics system. [http://www.pymol.org].
25. Chen D.Z., Patel D.V., Hackbarth C.J., Wang W., Dreyer G., Young D.C., Margolis P.S., Wu C., Ni Z.J., Trias J., White R.J., and Yuan Z. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry 39 (2000) 1256-1262
26. Kumar A., Nguyen K.T., Srivathsan S., Ornstein B., Turley S., Hirsh I., Pei D., and Hol W.G. Crystals of peptide deformylase from Plasmodium falciparum reveal critical characteristics of the active site for drug design. Structure 10 (2002) 357-367
27. Meinnel T., and Blanquet S. Enzymatic properties of Escherichia coli peptide deformylase. J. Bacteriol. 177 (1995) 1883-1887
28. Meinnel T., Lazennec C., Villoing S., and Blanquet S. Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion. J. Mol. Biol. 267 (1997) 749-761
29. Becker A., Schlichting I., Kabsch W., Schultz S., and Wagner A.F. Structure of peptide deformylase and identification of the substrate binding site. J. Biol. Chem. 273 (1998) 11413-11416